Cooler Heads

Executive Summary

Cooler Heads is a San Diego-based medical device company that developed Amma™, an FDA-cleared scalp cooling system designed to reduce chemotherapy-induced hair loss. Unlike traditional cold-cap systems that are bulky and require specialized clinic installation, Amma is portable, patient-friendly, and suitable for at-home or clinic use. The device delivers consistent, hospital-grade cooling to the scalp, preserving hair follicles during treatment. By addressing a significant quality-of-life concern for cancer patients, Cooler Heads aims to improve treatment adherence and patient well-being. The scalp cooling market is growing as awareness of hair preservation increases, yet adoption remains limited by reimbursement and access barriers. Cooler Heads differentiates itself through ease of use and a patient-first design, positioning it well for expansion across oncology centers. The company's primary challenges include securing broader insurance coverage, competing with established players like Penguin Cold Caps, and scaling manufacturing. If Cooler Heads successfully navigates these hurdles, it could capture a meaningful share of the US scalp cooling market, which serves over 650,000 chemotherapy patients annually. The company's path to growth hinges on clinical evidence, partnerships, and payer adoption.

Upcoming Catalysts (preview)

• Q4 2026FDA Clearance for Expanded Indication or Design Iteration75% success
• TBDPublication of Clinical Study Data Demonstrating Superior Hair Retention70% success
• TBDStrategic Reimbursement Agreement with Major Payer50% success